New findings published in the Nicotine and Tobacco Research journal by UC Davis Comprehensive Cancer tobacco researchers may lead to urgent recommendations for doctors to help patients quit smoking as a way of countering COVID-19.
UC San Diego Health is the first hospital system in the region to offer a novel treatment option for patients with prostate cancer that has spread throughout the body and has not responded to other therapeutics. In 2004, upon Jim Duvall’s completion of service in the U.S. Army, college and…
The National Center for Interventional Biophotonic Technologies hosted its inaugural symposium September 29 and 30, bringing together leading researchers from 13 institutions. The light-based technologies being developed have the potential to transform how diseases are diagnosed, managed, and treated.
UC Davis Health neuroscientist Sergey Stavisky was selected by the National Institutes of Health to receive the 2022 NIH Director’s New Innovator Award. The $2.3 million award will fund his research on medical devices implanted in the brain to restore speech.
David Tom Cooke, UC Davis oncology surgeon and chief of the Division of General Thoracic Surgery, has received the 2022 Ethnic Physician Leadership Award. He was recognized for his work to improve community health and reduce health disparities in California.
Season 4 of Unfold, a UC Davis podcast, is focused on leading-edge technologies and treatments that help advance the health of both people and animals. The first episode, “Hope for a Spina Bifida Cure, Part 1,” about a groundbreaking treatment for spina bifida in bulldogs, is now available.
Last month new “bivalent” booster vaccines made by Moderna and Pfizer became available that protect against currently circulating Omicron variants as well as earlier strains of the SARS-CoV-2 virus that causes COVID-19. This Q&A features Joel Ernst, MD, a UCSF professor of medicine whose research aims to understand how pathogens…
